Business Standard

Friday, December 20, 2024 | 04:46 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech

Image

At meeting held on 25 October 2024

The Board of Eris Lifesciences at its meeting held on 25 October 2024 has approved the execution of Binding Term Sheet with Levim Lifetech and its shareholders for the purpose of acquiring 30% stake in Levim Lifetech for an investment of Rs 54 crore at a pre-money equity valuation of Rs 126 crore. The acquisition is aimed at expansion of the company's biotechnology footprint across a wide range of products and technologies.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 25 2024 | 6:47 PM IST

Explore News